- increased circulating sodium level / IMPC
- thrombocytopenia / IMPC
- increased circulating total protein level / IMPC
- decreased circulating free fatty acids level / IMPC
- decreased fasting circulating glucose level / IMPC
- decreased erythrocyte cell number / IMPC
- increased mean corpuscular volume / IMPC
- increased mean corpuscular hemoglobin / IMPC
B6.129P2-Irf8tm1Hor/Kctt
Status | Available to order |
EMMA ID | EM:02414 |
International strain name | B6.129P2-Irf8tm1Hor/Kctt |
Alternative name | Irf8-/- |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Irf8tm1Hor |
Gene/Transgene symbol | Irf8 |
Information from provider
Provider | Ivan Horak |
Provider affiliation | Leibniz-Institut für Molekulare Pharmakologie |
Genetic information | A PGK-neomycin gene was inserted into the second exon of the Irf8 gene, disrupting sequences encoding the DNA binding domain. |
Phenotypic information | Abnormal hematopoiesis. |
References |
|
Information from EMMA
Archiving centre | Karolinska Institutet, Stockholm, Sweden |
Disease and phenotype information
MGI allele-associated human disease models
Orphanet associated rare diseases, based on orthologous gene matching
- Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency / Orphanet_319600
IMPC phenotypes (gene matching)
MGI phenotypes (allele matching)
- premature death / MGI
- abnormal definitive hematopoiesis / MGI
- increased chronic myelocytic leukemia incidence / MGI
- increased B-1b cell number / MGI
- decreased follicular B cell number / MGI
- increased marginal zone B cell number / MGI
- increased leukocyte cell number / MGI
- abnormal erythropoiesis / MGI
- increased bone marrow cell number / MGI
- increased granulocyte number / MGI
- enlarged liver / MGI
- enlarged spleen / MGI
- spleen hyperplasia / MGI
- enlarged lymph nodes / MGI
- abnormal megakaryocyte morphology / MGI
- increased susceptibility to viral infection / MGI
- increased immunoglobulin level / MGI
- increased lymphocyte cell number / MGI
- increased B cell number / MGI
- decreased lymphocyte cell number / MGI
- decreased B cell number / MGI
- decreased T cell number / MGI
- abnormal cytotoxic T cell physiology / MGI
- increased macrophage cell number / MGI
- abnormal plasma cell number / MGI
- increased mature B cell number / MGI
- increased spleen red pulp amount / MGI
- decreased interferon-gamma secretion / MGI
- increased sensitivity to induced morbidity/mortality / MGI
- increased lymphoma incidence / MGI
- abnormal humoral immune response / MGI
MGI phenotypes (gene matching)
- increased leukocyte cell number / MGI
- increased neutrophil cell number / MGI
- decreased monocyte cell number / MGI
- abnormal erythropoiesis / MGI
- increased bone marrow cell number / MGI
- increased granulocyte number / MGI
- enlarged liver / MGI
- enlarged spleen / MGI
- spleen hyperplasia / MGI
- enlarged lymph nodes / MGI
- abnormal myelopoiesis / MGI
- abnormal humoral immune response / MGI
- premature death / MGI
- abnormal definitive hematopoiesis / MGI
- no abnormal phenotype detected / MGI
- abnormal megakaryocyte morphology / MGI
- increased susceptibility to viral infection / MGI
- increased immunoglobulin level / MGI
- no phenotypic analysis / MGI
- decreased macrophage cell number / MGI
- increased lymphocyte cell number / MGI
- increased B cell number / MGI
- decreased lymphocyte cell number / MGI
- decreased B cell number / MGI
- decreased T cell number / MGI
- abnormal cytotoxic T cell physiology / MGI
- increased macrophage cell number / MGI
- increased chronic myelocytic leukemia incidence / MGI
- abnormal plasma cell number / MGI
- increased B-1b cell number / MGI
- increased follicular B cell number / MGI
- decreased follicular B cell number / MGI
- increased marginal zone B cell number / MGI
- increased transitional stage B cell number / MGI
- increased mature B cell number / MGI
- increased spleen red pulp amount / MGI
- abnormal interferon secretion / MGI
- decreased interferon-gamma secretion / MGI
- increased sensitivity to induced morbidity/mortality / MGI
- increased lymphoma incidence / MGI
Literature references
- Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis.;Fehr T, Schoedon G, Odermatt B, Holtschke T, Schneemann M, Bachmann M F, Mak T W, Horak I, Zinkernagel R M, ;1997;The Journal of experimental medicine;185;921-31; 9120398
- Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction.;Scharton-Kersten T, Contursi C, Masumi A, Sher A, Ozato K, ;1997;The Journal of experimental medicine;186;1523-34; 9348310
- Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression.;Giese N A, Gabriele L, Doherty T M, Klinman D M, Tadesse-Heath L, Contursi C, Epstein S L, Morse H C, ;1997;The Journal of experimental medicine;186;1535-46; 9348311
- Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias.;Schmidt M, Nagel S, Proba J, Thiede C, Ritter M, Waring J F, Rosenbauer F, Huhn D, Wittig B, Horak I, Neubauer A, ;1998;Blood;91;22-9; 9414265
- Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein.;Scheller M, Foerster J, Heyworth C M, Waring J F, Löhler J, Gilmore G L, Shadduck R K, Dexter T M, Horak I, ;1999;Blood;94;3764-71; 10572090
- ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells.;Schiavoni Giovanna, Mattei Fabrizio, Sestili Paola, Borghi Paola, Venditti Massimo, Morse Herbert C, Belardelli Filippo, Gabriele Lucia, ;2002;The Journal of experimental medicine;196;1415-25; 12461077
- AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency.;Schwieger Maike, Löhler Jürgen, Friel Jutta, Scheller Marina, Horak Ivan, Stocking Carol, ;2002;The Journal of experimental medicine;196;1227-40; 12417632
- Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells.;Aliberti Julio, Schulz Oliver, Pennington Daniel J, Tsujimura Hideki, Reis e Sousa Caetano, Ozato Keiko, Sher Alan, ;2003;Blood;101;305-10; 12393690
- Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene.;Holtschke T, Löhler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, Lou J, Knobeloch K P, Gabriele L, Waring J F, Bachmann M F, Zinkernagel R M, Morse H C, Ozato K, Horak I, ;1996;Cell;87;307-17; 8861914
- Interferon regulatory factor 8 protects against cerebral ischaemic-reperfusion injury.;Xiang Mei, Wang Lang, Guo Sen, Lu Yan-Yun, Lei Hao, Jiang Ding-Sheng, Zhang Yan, Liu Yi, Zhou Yan, Zhang Xiao-Dong, Li Hongliang, ;2014;Journal of neurochemistry;129;988-1001; 24528256
- IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling.;Jiang Ding-Sheng, Wei Xiang, Zhang Xiao-Fei, Liu Yu, Zhang Yan, Chen Ke, Gao Lu, Zhou Heng, Zhu Xue-Hai, Liu Peter P, Bond Lau Wayne, Ma Xinliang, Zou Yunzeng, Zhang Xiao-Dong, Fan Guo-Chang, Li Hongliang, ;2014;Nature communications;5;3303; 24526256
- Interferon regulatory factor 8 modulates phenotypic switching of smooth muscle cells by regulating the activity of myocardin.;Zhang Shu-Min, Gao Lu, Zhang Xiao-Fei, Zhang Ran, Zhu Li-Hua, Wang Pi-Xiao, Tian Song, Yang Da, Chen Ke, Huang Ling, Zhang Xiao-Dong, Li Hongliang, ;2014;Molecular and cellular biology;34;400-14; 24248596
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).